• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蕈样肉芽肿和赛泽里综合征的简化流式细胞术评估。

Simplified flow cytometric assessment in mycosis fungoides and Sézary syndrome.

机构信息

Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

出版信息

Am J Clin Pathol. 2011 Dec;136(6):944-53. doi: 10.1309/AJCP09OTJOYAVZZK.

DOI:10.1309/AJCP09OTJOYAVZZK
PMID:22095381
Abstract

By using flow cytometry with markers for CD3, CD4, CD26, and CD7, we examined the blood samples of 109 patients for abnormal T cells: 69 patients with mycosis fungoides (MF)/Sézary syndrome (SS), 31 hospitalized control subjects, and 9 patients with inflammatory skin disease. T cells were identified as quantitatively abnormal (>15% CD26- or CD7- T cells) or phenotypically abnormal (CD26- or CD7- T cells with bright or dim CD3 or CD4 or bright CD7). Patients were followed for a median of 82 months, and abnormal T cells were correlated with diagnosis, clinical outcome, and other laboratory parameters. Abnormal T-cell populations were identified in 46% of patients with MF/SS (32/69) and correlated with disease extent. Quantitative abnormalities were more frequent than phenotypic abnormalities, and CD4+/CD26- T cells were more frequent than CD4+/CD7- T cells. CD26- T cells correlated better with disease extent than did CD7 -. Increasing numbers of abnormal T cells were associated with worsening disease. Flow cytometry provides valuable information for diagnosis, prognosis, and therapeutic efficacy in MF/SS.

摘要

我们使用流式细胞术检测 CD3、CD4、CD26 和 CD7 标志物,对 109 名患者的血液样本进行异常 T 细胞检测:69 名蕈样肉芽肿(MF)/Sézary 综合征(SS)患者、31 名住院对照患者和 9 名炎症性皮肤病患者。T 细胞被确定为数量异常(>15%的 CD26-或 CD7-T 细胞)或表型异常(CD26-或 CD7-T 细胞,具有明亮或暗淡的 CD3 或 CD4 或明亮的 CD7)。对患者进行中位数为 82 个月的随访,异常 T 细胞与诊断、临床结果和其他实验室参数相关。在 46%的 MF/SS 患者(32/69)中发现异常 T 细胞群,与疾病范围相关。定量异常比表型异常更常见,CD4+/CD26-T 细胞比 CD4+/CD7-T 细胞更常见。与 CD7-相比,CD26-T 细胞与疾病范围的相关性更好。异常 T 细胞数量的增加与疾病恶化相关。流式细胞术为 MF/SS 的诊断、预后和治疗效果提供了有价值的信息。

相似文献

1
Simplified flow cytometric assessment in mycosis fungoides and Sézary syndrome.蕈样肉芽肿和赛泽里综合征的简化流式细胞术评估。
Am J Clin Pathol. 2011 Dec;136(6):944-53. doi: 10.1309/AJCP09OTJOYAVZZK.
2
Determination of immunophenotypic aberrancies provides better assessment of peripheral blood involvement by mycosis fungoides/Sézary syndrome than quantification of CD26- or CD7- CD4+ T-cells.与定量检测 CD26- 或 CD7- CD4+ T 细胞相比,免疫表型异常的确定能更好地评估蕈样肉芽肿/赛泽里综合征外周血受累情况。
Cytometry B Clin Cytom. 2021 Mar;100(2):183-191. doi: 10.1002/cyto.b.21933. Epub 2020 Jul 15.
3
Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome.外周血中皮肤归巢CLA+ CD4+ T淋巴细胞上CD26表达缺失是蕈样肉芽肿患者早期诊断和治疗监测的高度敏感标志物。
Clin Exp Dermatol. 2005 Nov;30(6):702-6. doi: 10.1111/j.1365-2230.2005.01904.x.
4
Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood.CD26表达缺失是外周血中T细胞淋巴瘤诊断的有用标志物。
Am J Clin Pathol. 2001 Jun;115(6):885-92. doi: 10.1309/U1Y6-J4AG-5M4M-7AYV.
5
CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome.CD4(+)CD7(-) T细胞构成了蕈样肉芽肿综合征患者外周血中占主导地位的T细胞克隆。
J Am Acad Dermatol. 2001 Mar;44(3):456-61. doi: 10.1067/mjd.2001.110900.
6
Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndrome.蕈样肉芽肿患者临床状态变化与CD4+CD26-淋巴细胞群体百分比变化的关联。
J Am Acad Dermatol. 2005 Sep;53(3):428-34. doi: 10.1016/j.jaad.2005.06.001.
7
Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome.流式细胞术免疫表型分析和DNA倍体研究在诊断和表征CD4 + 蕈样肉芽肿综合征血液受累中的应用。
Haematologica. 2003 Aug;88(8):874-87.
8
Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7- T helper lymphocytes expansion.与CD7⁻辅助性T淋巴细胞扩增相关的皮肤T细胞淋巴瘤患者循环细胞中激活、分化和归巢相关抗原的表达失衡。
J Invest Dermatol. 1999 Oct;113(4):622-7. doi: 10.1046/j.1523-1747.1999.00718.x.
9
Leu-8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values.CD3⁺ T细胞的Leu-8/CD7抗原表达:蕈样肉芽肿/塞扎里综合征患者皮肤和血液与正常血液值的比较分析
J Am Acad Dermatol. 1990 Apr;22(4):602-7. doi: 10.1016/0190-9622(90)70080-2.
10
[Clinicomorphological characteristics of Sezary's disease and mycosis fungoides].[覃样肉芽肿病和蕈样霉菌病的临床形态学特征]
Ter Arkh. 2005;77(10):61-5.

引用本文的文献

1
Mycosis Fungoides, Sézary Syndrome, and Cutaneous B-Cell Lymphomas: 2025 Update on Diagnosis, Risk-Stratification, and Management.蕈样肉芽肿、塞扎里综合征和皮肤B细胞淋巴瘤:2025年诊断、风险分层及管理的最新进展
Am J Hematol. 2025 Sep;100(9):1603-1628. doi: 10.1002/ajh.27735. Epub 2025 Jun 10.
2
Sézary Syndrome in West Sweden: Exploring Epidemiology, Clinical Features, and Treatment Patterns in a Registry-Based Retrospective Analysis.瑞典西部的塞扎里综合征:基于登记处的回顾性分析探索其流行病学、临床特征及治疗模式
Cancers (Basel). 2024 May 21;16(11):1948. doi: 10.3390/cancers16111948.
3
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers.
靶向 TRBC1 的抗体药物偶联物用于治疗 T 细胞癌症。
Nature. 2024 Apr;628(8007):416-423. doi: 10.1038/s41586-024-07233-2. Epub 2024 Mar 27.
4
HLA-DR Helps to Differentiate Erythrodermic Cutaneous T-cell Lymphoma from Erythrodermic Inflammatory Dermatoses in Flow Cytometry.HLA-DR 有助于流式细胞术区分红皮病性皮肤 T 细胞淋巴瘤与红皮病性炎症性皮肤病。
Acta Derm Venereol. 2023 Aug 1;103:adv5668. doi: 10.2340/actadv.v103.5668.
5
Mycosis fungoides and Sézary syndrome.蕈样肉芽肿和塞扎里综合征。
Blood Res. 2023 Apr 30;58(S1):66-82. doi: 10.5045/br.2023.2023023.
6
Cutaneous T-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management.皮肤 T 细胞淋巴瘤:2023 年诊断、风险分层和治疗更新。
Am J Hematol. 2023 Jan;98(1):193-209. doi: 10.1002/ajh.26760. Epub 2022 Oct 20.
7
CD26/DPP-4 in Chronic Myeloid Leukemia.慢性髓性白血病中的CD26/二肽基肽酶-4
Cancers (Basel). 2022 Feb 11;14(4):891. doi: 10.3390/cancers14040891.
8
Flow cytometry for the assessment of blood tumour burden in cutaneous T-cell lymphoma: towards a standardized approach.流式细胞术评估皮肤 T 细胞淋巴瘤的血液肿瘤负担:迈向标准化方法。
Br J Dermatol. 2022 Jul;187(1):21-28. doi: 10.1111/bjd.21053. Epub 2022 May 3.
9
The Serine Protease CD26/DPP4 in Non-Transformed and Malignant T Cells.非转化和恶性T细胞中的丝氨酸蛋白酶CD26/DPP4
Cancers (Basel). 2021 Nov 26;13(23):5947. doi: 10.3390/cancers13235947.
10
Reactive Langerhans Cell Proliferation Mimicking Langerhans Cell Histiocytosis in Association with Sézary Syndrome: A Case Report and Literature Review.反应性朗格汉斯细胞增生症酷似朗格汉斯细胞组织细胞增多症并与蕈样肉芽肿相关:一例报告及文献复习
Clin Cosmet Investig Dermatol. 2021 Aug 24;14:1023-1028. doi: 10.2147/CCID.S323865. eCollection 2021.